Mechanistically, the authors observed that a greater expression of the oncogenic miR-155 in CLL caused a sequence-specific suppression of the expression of MARCKS thereby controlling its cellular levels. The gene discussed is MARCKS; the disease is B-cell chronic lymphocytic leukemia.